Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ProPhase Labs Inc. (PRPH) stock rises in after-hour trading. Why is it so?

By ST Staff
Published On March 31, 2021 6:50 AM UTC
ProPhase Labs Inc. (PRPH) stock rises in after-hour trading. Why is it so?

Surged by 1.29% in the last trading close whereas the PRPH stock price continued to rise by 32.06% during the after-hours trading as PRPH made an announcement that they have managed to get the “VaccTrack” suite of digital solutions which is designed to provide safe and reliable certification of the person’s vaccination and also Covid testing results. ProPhase is a technology company that focuses on medical science. ProPhase Diagnostics, which is the laboratory testing subsidiary of ProPhase, provides SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests via saliva and nasal swab at its CLIA-certified laboratories.

Digital Vaccination Certificate; a significant development

The digital vaccination certificate, or “passport,” is built on a mobile app that works in a way that indicates that a user has been vaccinated against Covid-19, or can validate the test results if the user has been checked for Covid-19. In this digital solution of PRPH, It is expected that confirming that a person has been vaccinated or tested negative for the virus would be widely accepted as a measure that will allow entertainment and sporting places to safely admit visitors, as well as airlines and hotels to securely admit tourists. The VaccTrack solution is designed by PRPH to be used as an app on a cell phone or as a digital wallet.

The VaccTrack developed by PRPH is a four-in-one solution that includes VaccTrack for vaccine certificates, VaccTest for screening test certificates, VaccCheck to authenticate VaccTrack and VaccTest certificates, and VaccWatch to monitor vaccination side effects, and will be conveniently incorporated into any organization’s existing Covid testing operations.

Lastly,

Bedis Zormati who has developed this digital solution said that they are highly fortunate that ProPhase Labs will now provide VaccTrack to enhance the value and usability of PRPH’s research and diagnostic services. When users can take their vaccine certificates, as well as Covid and other testing results, back into the real world and resume their usual lives and social activities, the program speeds up. Also, they are really hyped to collaborate with the ProPhase team.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph